Sort   by:  
 Page size 
UnknownMad2 inhibits the mitotic kinesin MKlp2.
Not available
S-EPMC3002031 | biostudies-literature
UnknownGenotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
Not available
S-EPMC3360787 | biostudies-literature
UnknownDual gene activation and knockout screen reveals directional dependencies in genetic networks.
Not available
S-EPMC6072461 | biostudies-literature
UnknownBiochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.
Not available
S-EPMC6983858 | biostudies-literature
UnknownDual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality.
Not available
S-EPMC5736559 | biostudies-literature
UnknownBreast cancer, version 3.2013: featured updates to the NCCN guidelines.
Not available
S-EPMC3991132 | biostudies-literature
UnknownAntitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.
Not available
S-EPMC3913610 | biostudies-literature
UnknownImpaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Not available
S-EPMC9533010 | biostudies-literature
UnknownMinor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.
Not available
S-EPMC8177065 | biostudies-literature
UnknownARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.
Not available
S-EPMC9271631 | biostudies-literature
Sort   by:  
 Page size